HRP20010057A2 - Phthalazine derivatives phosphodiesterase 4 inhibitors - Google Patents
Phthalazine derivatives phosphodiesterase 4 inhibitors Download PDFInfo
- Publication number
- HRP20010057A2 HRP20010057A2 HR20010057A HRP20010057A HRP20010057A2 HR P20010057 A2 HRP20010057 A2 HR P20010057A2 HR 20010057 A HR20010057 A HR 20010057A HR P20010057 A HRP20010057 A HR P20010057A HR P20010057 A2 HRP20010057 A2 HR P20010057A2
- Authority
- HR
- Croatia
- Prior art keywords
- mmol
- methoxy
- dichloro
- pyridin
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Macromonomer-Based Addition Polymer (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT98MI001670A ITMI981670A1 (it) | 1998-07-21 | 1998-07-21 | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| PCT/EP1999/004904 WO2000005218A1 (en) | 1998-07-21 | 1999-07-13 | Phthalazine derivatives phosphodiesterase 4 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20010057A2 true HRP20010057A2 (en) | 2002-04-30 |
Family
ID=11380474
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20010057A HRP20010057A2 (en) | 1998-07-21 | 1999-07-13 | Phthalazine derivatives phosphodiesterase 4 inhibitors |
Country Status (35)
| Country | Link |
|---|---|
| US (2) | US6329370B1 (es) |
| EP (2) | EP1371648A1 (es) |
| JP (1) | JP2002521370A (es) |
| KR (1) | KR20010087161A (es) |
| CN (1) | CN1127486C (es) |
| AP (1) | AP2000001993A0 (es) |
| AR (1) | AR019409A1 (es) |
| AT (1) | ATE279397T1 (es) |
| AU (1) | AU765457B2 (es) |
| BG (1) | BG105063A (es) |
| BR (1) | BR9911175A (es) |
| CA (1) | CA2338044A1 (es) |
| CO (1) | CO5090842A1 (es) |
| DE (1) | DE69921139T2 (es) |
| EA (1) | EA200100062A1 (es) |
| EE (1) | EE200100039A (es) |
| HK (1) | HK1039124B (es) |
| HR (1) | HRP20010057A2 (es) |
| HU (1) | HUP0102646A3 (es) |
| ID (1) | ID28874A (es) |
| IL (1) | IL139490A0 (es) |
| IS (1) | IS5772A (es) |
| IT (1) | ITMI981670A1 (es) |
| MX (1) | MXPA01000670A (es) |
| NO (1) | NO318988B1 (es) |
| NZ (1) | NZ507926A (es) |
| OA (1) | OA11582A (es) |
| PA (1) | PA8478301A1 (es) |
| PE (1) | PE20000755A1 (es) |
| PL (1) | PL345187A1 (es) |
| SK (1) | SK1002001A3 (es) |
| TW (1) | TW509682B (es) |
| UA (1) | UA68383C2 (es) |
| WO (1) | WO2000005218A1 (es) |
| YU (1) | YU77500A (es) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
| ITMI981671A1 (it) | 1998-07-21 | 2000-01-21 | Zambon Spa | Derivati ftalazinici inibitori della fosfodisterasi 4 |
| DE19921567A1 (de) * | 1999-05-11 | 2000-11-16 | Basf Ag | Verwendung von Phthalazine-Derivaten |
| DE19963607B4 (de) * | 1999-12-23 | 2005-12-15 | Schering Ag | Verfahren zur Herstellung von 4-(Heteroaryl-methyl) halogen-1(2H)-phthalazinonen |
| ITMI20000261A1 (it) * | 2000-02-16 | 2001-08-16 | Zambon Group | Processo per la preparazione di piridiniliden-ftalidi |
| US6703390B2 (en) * | 2000-04-13 | 2004-03-09 | Transgenomic, Inc. | Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors |
| US6525049B2 (en) * | 2000-07-05 | 2003-02-25 | Pharmacia & Upjohn Company | Pyrroloquinolones as antiviral agents |
| AU2002220241A1 (en) * | 2000-12-01 | 2002-06-11 | Iconix Pharmaceuticals, Inc. | Parb inhibitors |
| ITMI20022738A1 (it) * | 2002-12-23 | 2004-06-24 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4. |
| ITMI20022739A1 (it) * | 2002-12-23 | 2004-06-24 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4. |
| US7652036B2 (en) | 2003-02-25 | 2010-01-26 | Topotarget Uk Limited | Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors |
| ITMI20031451A1 (it) * | 2003-07-16 | 2005-01-17 | Zambon Spa | Derivati diidro-ftalazinici inibitori della fosfodiesterasi 4 |
| US8338591B2 (en) * | 2004-05-08 | 2012-12-25 | Novartis International Pharmaceutical Ltd. | 3-aryl-5,6-disubstituted pyridazines |
| CA2593005A1 (en) * | 2005-01-03 | 2006-07-13 | Myriad Genetics Inc. | Pharmaceutical compounds as activators of caspases and inducers of apoptosis and the use thereof |
| EP1948164A1 (en) | 2005-10-19 | 2008-07-30 | Ranbaxy Laboratories, Ltd. | Pharmaceutical compositions of muscarinic receptor antagonists |
| US8044041B2 (en) | 2006-11-15 | 2011-10-25 | Forest Laboratories Holdings Limited | Phthalazine derivatives as inhibitors of protein kinase |
| EP2323991B1 (en) * | 2008-08-13 | 2017-05-31 | Boehringer Ingelheim International GmbH | Chymase inhibitors |
| CN102108078B (zh) * | 2009-12-24 | 2013-10-30 | 沈阳药科大学 | 1,4-取代酞嗪类化合物及其制备方法和用途 |
| CN104203919A (zh) * | 2011-11-09 | 2014-12-10 | 艾伯维德国有限责任两合公司 | 可用作10a型磷酸二酯酶的抑制剂的杂环甲酰胺类 |
| CN117924243B (zh) * | 2024-01-16 | 2025-09-12 | 沈阳药科大学 | 一种喹啉衍生物及其药用组合物和应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2063249A (en) * | 1979-10-09 | 1981-06-03 | Mitsubishi Yuka Pharma | 4-Phenylphthalazine derivatives |
| JPH03106873A (ja) * | 1989-09-20 | 1991-05-07 | Morishita Pharmaceut Co Ltd | 1―ピリジルフタラジン誘導体及びそれらを含有する血小板凝集抑制剤 |
| EP0449203B1 (en) * | 1990-03-30 | 1994-12-07 | Mitsubishi Chemical Corporation | 4-Phenylphthalazine derivatives |
| EP0634404A1 (en) * | 1993-07-13 | 1995-01-18 | Rhone Poulenc Agriculture Ltd. | Phtalazin derivatives and their use as pesticides |
| HU219864B (hu) * | 1994-08-09 | 2001-08-28 | Eisai Co., Ltd. | cGMP-PDE inhibitor kondenzált piridazinszármazékok és alkalmazásuk |
| IT1296984B1 (it) * | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati ftalazinici inibitori della fosfodiesterasi 4 |
-
1998
- 1998-07-21 IT IT98MI001670A patent/ITMI981670A1/it unknown
-
1999
- 1999-07-08 PE PE1999000670A patent/PE20000755A1/es not_active Application Discontinuation
- 1999-07-13 WO PCT/EP1999/004904 patent/WO2000005218A1/en not_active Ceased
- 1999-07-13 BR BR9911175-6A patent/BR9911175A/pt not_active IP Right Cessation
- 1999-07-13 UA UA2001010439A patent/UA68383C2/uk unknown
- 1999-07-13 CA CA002338044A patent/CA2338044A1/en not_active Abandoned
- 1999-07-13 US US09/743,813 patent/US6329370B1/en not_active Expired - Fee Related
- 1999-07-13 AP APAP/P/2000/001993A patent/AP2000001993A0/en unknown
- 1999-07-13 DE DE69921139T patent/DE69921139T2/de not_active Expired - Fee Related
- 1999-07-13 AU AU52810/99A patent/AU765457B2/en not_active Ceased
- 1999-07-13 SK SK100-2001A patent/SK1002001A3/sk unknown
- 1999-07-13 HU HU0102646A patent/HUP0102646A3/hu unknown
- 1999-07-13 MX MXPA01000670A patent/MXPA01000670A/es not_active Application Discontinuation
- 1999-07-13 CN CN99807294A patent/CN1127486C/zh not_active Expired - Fee Related
- 1999-07-13 IL IL13949099A patent/IL139490A0/xx not_active IP Right Cessation
- 1999-07-13 HK HK02100584.0A patent/HK1039124B/zh not_active IP Right Cessation
- 1999-07-13 HR HR20010057A patent/HRP20010057A2/hr not_active Application Discontinuation
- 1999-07-13 EE EEP200100039A patent/EE200100039A/xx unknown
- 1999-07-13 YU YU77500A patent/YU77500A/sh unknown
- 1999-07-13 OA OA1200100019A patent/OA11582A/en unknown
- 1999-07-13 NZ NZ507926A patent/NZ507926A/xx unknown
- 1999-07-13 EA EA200100062A patent/EA200100062A1/ru unknown
- 1999-07-13 ID IDW20010132A patent/ID28874A/id unknown
- 1999-07-13 EP EP03102377A patent/EP1371648A1/en not_active Withdrawn
- 1999-07-13 JP JP2000561174A patent/JP2002521370A/ja active Pending
- 1999-07-13 KR KR1020017000971A patent/KR20010087161A/ko not_active Ceased
- 1999-07-13 PL PL99345187A patent/PL345187A1/xx not_active Application Discontinuation
- 1999-07-13 AT AT99938229T patent/ATE279397T1/de not_active IP Right Cessation
- 1999-07-13 EP EP99938229A patent/EP1097142B1/en not_active Expired - Lifetime
- 1999-07-16 AR ARP990103501A patent/AR019409A1/es unknown
- 1999-07-19 CO CO99045518A patent/CO5090842A1/es unknown
- 1999-07-19 TW TW088112218A patent/TW509682B/zh not_active IP Right Cessation
- 1999-07-19 PA PA19998478301A patent/PA8478301A1/es unknown
-
2000
- 2000-12-15 IS IS5772A patent/IS5772A/is unknown
- 2000-12-18 BG BG105063A patent/BG105063A/xx unknown
-
2001
- 2001-01-19 NO NO20010331A patent/NO318988B1/no not_active IP Right Cessation
- 2001-10-15 US US09/976,436 patent/US6492360B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20010057A2 (en) | Phthalazine derivatives phosphodiesterase 4 inhibitors | |
| JP2923742B2 (ja) | 4−アミノキナゾリン誘導体、その製造方法およびそれを含有する医薬品 | |
| EP0418845B1 (en) | Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same | |
| US6340684B1 (en) | Phthalazine derivatives as phosphodiesterase 4 inhibitors | |
| JP4285602B2 (ja) | 抗炎症剤 | |
| CA2534649A1 (en) | Bicyclic imidazol derivatives against flaviviridae | |
| BG105620A (bg) | Заместени пиразоли като инхибитори на р38 киназата | |
| SI9200095A (en) | Heterocyclic derivatives | |
| CA2401667A1 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
| HRP20050199A2 (hr) | Novi derivati piridazinona | |
| BRPI0806566A2 (pt) | Derivados de glicina n-substituída: inibidores de hidroxilase | |
| JPH0794454B2 (ja) | ピラゾロピリジン化合物およびその製造法 | |
| JP2012509263A (ja) | 四置換ピリダジンヘッジホッグ経路アンタゴニスト | |
| US6525055B1 (en) | Tricyclic phthalazine derivatives as phosphodiesterase 4 inhibitors | |
| IE61045B1 (en) | 4-aryl-5-carbamoyl-1, 4-dihydropyridines | |
| RS20060206A (sr) | Derivati aminopiridina kao inhibitori inducibilne no-sintaze | |
| RS20060195A (sr) | Imidazopiridinski derivati kao inhibitori inducibilne no-sintaze | |
| WO1995002596A1 (en) | Azacyclic-heterocyclic compounds as angiotensin ii receptor antagonists | |
| SK12102002A3 (sk) | 4-oxo-1,4-dihydro-3-cinolínkarboxamidy ako antivírusové látky | |
| CZ2001241A3 (cs) | Ftalazinové deriváty | |
| AU2014271290B2 (en) | Androgen receptor modulators and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20050203 Year of fee payment: 4 |
|
| OBST | Application withdrawn |